Navarra, Spain

Iván Peñuelas Sánchez


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Iván Peñuelas Sánchez: Innovator in Nanomedicine

Introduction

Iván Peñuelas Sánchez is a notable inventor based in Navarra, Spain. He has made significant contributions to the field of nanomedicine, particularly in the development of innovative treatments for cancer and ocular diseases. His work exemplifies the intersection of science and technology, aiming to improve patient outcomes through advanced medical solutions.

Latest Patents

One of his key patents is focused on albumin nanoparticles designed for therapeutic use. The patent, titled "Albumin nanoparticles for the treatment of cancer and ocular diseases," describes nanoparticles that consist of a core made from a non-crosslinked albumin matrix and a monoclonal antibody. These nanoparticles may also be coated with a non-ionic polymer to enhance their effectiveness as a medicament. This invention holds promise for the treatment of various cancers and ocular conditions, showcasing the potential of nanotechnology in medicine. He holds 1 patent.

Career Highlights

Throughout his career, Iván has worked with prestigious institutions, including the National University of Córdoba and the National Scientific and Technical Research Council (CONICET). His experience in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.

Collaborations

Some of his notable coworkers include Daniel Alberto Allemandi and Carolina Boiero. Their collaborative efforts have further advanced the research and development of innovative medical treatments.

Conclusion

Iván Peñuelas Sánchez is a distinguished inventor whose work in nanomedicine is paving the way for new therapeutic approaches to cancer and ocular diseases. His contributions are vital to the ongoing evolution of medical science, and his innovative spirit continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…